Kristina Masson

Companies

• Acrivon Therapeutics, Inc.Board member Nov 9, 2022 to now¹
• Acrivon Therapeutics, Inc.EVP - Business Operations Nov 9, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAcrivon Therapeutics, Inc. ACRV2,629,947 shares²$4.5M at $1.70Aug 18, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 18, 2026Sold 484 shares at $2.01 of Acrivon Therapeutics, Inc.²
• Aug 18, 2026Sold 1,229 shares at $2.01 of Acrivon Therapeutics, Inc.²
• May 21, 2026Shares withheld for tax 13,729 shares at $1.79 of Acrivon Therapeutics, Inc.³
• Nov 21, 2025Shares withheld for tax 19,904 shares at $2.30 of Acrivon Therapeutics, Inc.⁴
• Nov 14, 2025Shares withheld for tax 490 shares at $2.24 of Acrivon Therapeutics, Inc.⁵
• Nov 14, 2025Shares withheld for tax 59,765 shares at $2.24 of Acrivon Therapeutics, Inc.⁵
• Aug 21, 2025Shares withheld for tax 19,905 shares at $1.32 of Acrivon Therapeutics, Inc.⁶
• Aug 14, 2025Shares withheld for tax 490 shares at $1.39 of Acrivon Therapeutics, Inc.⁷
• Aug 14, 2025Shares withheld for tax 59,766 shares at $1.39 of Acrivon Therapeutics, Inc.⁷
• Feb 14, 2025Shares withheld for tax 579 shares at $5.42 of Acrivon Therapeutics, Inc.⁸
• Feb 14, 2025Shares withheld for tax 37,152 shares at $5.42 of Acrivon Therapeutics, Inc.⁸
• Nov 21, 2024Shares withheld for tax 19,910 shares at $6.44 of Acrivon Therapeutics, Inc.⁹
• Aug 14, 2024Shares withheld for tax 490 shares at $7.02 of Acrivon Therapeutics, Inc.¹⁰
• May 14, 2024Shares withheld for tax 490 shares at $8.36 of Acrivon Therapeutics, Inc.¹¹
• Feb 14, 2024Shares withheld for tax 579 shares at $3.40 of Acrivon Therapeutics, Inc.¹²
• Nov 14, 2023Shares withheld for tax 1,900 shares at $5.08 of Acrivon Therapeutics, Inc.¹³
• Nov 14, 2022Granted 60,090 shares of Acrivon Therapeutics, Inc.¹⁴
• Nov 14, 2022Granted 503,419 shares of Acrivon Therapeutics, Inc.¹⁴
• Nov 14, 2022Granted 934,731 shares of Acrivon Therapeutics, Inc.¹⁴
• Nov 14, 2022Granted 26,707 shares of Acrivon Therapeutics, Inc.¹⁴